The following table provides an overview of the latest patents of Napp Pharmaceutical Holdings Limited that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2425821May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone21
EP2425824May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone20
EP1731152May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine5